R1R2

I have never seen an "extreme case" of antigen blocking resulting in a negative test and I would think that the baby would have a lot of other serological issues that might alert you that this might be going on. Our facility allows newborn weak D testing when the DAT is positive and most of the time the weak D is negative. If you have staff that can understand this process then it might be a good idea.

No you can't but you can run select cells instead of a full panel. You may even skip the antibody screen and go right to the select cell panel.

Your reverse cells are probably Rh- and may react with anti c. Using gel will only enhance this reaction since the plasma/cells are in contact for 10+ minutes or more especially if using automation. You probably ran your reverse tube without delay so you did not pick up the anti c. If you incubated your tube reverse B cell at 37 you would probably pick up some reactivity. I have seen this many times especially with anti c.

Our system dropped them 5+ years ago. We were and continue doing 2 samples for ABO Rh and electronic crossmatch. Our process for positive patient ID is 3 identifiers and labeling in the presence of the patient.

Yes, I have seen this many times since using the Provue. I think your theory about where the probe samples and where a human samples is correct.

Which one will you report in the EMR? A good response to your interviewer would be that you would consult the policy.

For a smaller hospital that does not "prepare" components this could apply to FFP that is thawed and a clot is present what steps do you take.

what is the standard?

I am curious about why the 30 minute gap between samples?

I was told that there are signatures of acceptability on the document.

Sounds like a leaky segment. Do you get the bag back so you could investigate? I would document this incident as a safety event.

Anytime you add humans to the process you will have manual result entry errors and WBITs. My suggestion is to document the errors and discuss with you one up and quality person. You are doing a lot of TASs to warrant an interface IMO.

These are just a couple of CAP requirements that deal with result review: GEN.43825 Result Verification - Manual and automated result entries are verified before final acceptance and reporting by the computer. An audit after the fact would not satisfy this requirement. COM.04100 Deals with Supervisory Result Review and all results need to be reviewed within 24 hours if high complexity testing is performed by trainined high school grads. It would also be a good idea to audit a percentage of results after the fact too if you are manually entering results into an LIS.

can we assume you are doing serological crossmatches on everyone (which would confirm your 1 and only blood type, sort of)?

I just answered this question. My Score FAIL